Table 3. Subgroup analysis assessing APLA and the risk of RVO by subtypes of APLA and RVO.
| Subgroup | No. of studies | Summary OR (95% CI) | Heterogeneity | |
|---|---|---|---|---|
| I 2 score (%) | P value | |||
| APLA for RVO | 11 | 5.18 [3.37, 7.95] | 0.00 | 0.909 |
| APLA for CRVO | 7 | 4.40 [2.06, 9.36] | 0.00 | 0.644 |
| APLA for BRVO | 4 | 10.09 [3.99, 25.50] | 0.00 | 0.413 |
| ACA for RVO | 8 | 4.59 [2.75, 7.66] | 0.00 | 0.720 |
| ACA for CRVO | 5 | 5.75 [2.25, 14.69] | 0.00 | 0.854 |
| ACA for BRVO | 4 | 7.50 [1.61, 35.03] | 27.80 | 0.245 |
| LA for RVO | 5 | 3.90 [0.99, 15.37] | 37.00 | 0.890 |
| LA for CRVO | 4 | 1.71 [0.69, 4.21] | 0.00 | 0.586 |